Jane E. Willoughby
- Immunology top 10%
- T-cell and B-cell Immunology 8
- Immune Cell Function and Interaction 7
- Immunotherapy and Immune Responses 7
- IL-33, ST2, and ILC Pathways 1
- Oncology top 10%
- CAR-T cell therapy research 2
- Cancer Immunotherapy and Biomarkers 2
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Cell Adhesion Molecules Research 1
- Co-authors
- Aymen Al‐ShamkhaniMark S. CraggSarah L. BuchanJordana GriffithsIvo TewsVadim Y. TarabanPeter JohnsonTomasz Ślebioda
- Journals
- The Journal of Immunology (3 papers)European Journal of Immunology (2 papers)Scientific Reports (1 paper)
- Partner nations
- United KingdomFranceUnited States
In The Last Decade
Jane E. Willoughby
12 papers receiving 565 citations
Peers
Comparison fields: 5 of 57
- Immunology 412
- Oncology 233
- Radiology, Nuclear Medicine and Imaging 122
- Immunology and Allergy 16
- Cancer Research 34
Countries citing papers authored by Jane E. Willoughby
This map shows the geographic impact of Jane E. Willoughby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane E. Willoughby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane E. Willoughby more than expected).
Fields of papers citing papers by Jane E. Willoughby
This network shows the impact of papers produced by Jane E. Willoughby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane E. Willoughby. The network helps show where Jane E. Willoughby may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jane E. Willoughby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 28 | |
| 2 | 2018 | 30 | |
| 3 | 2018 | 1 | |
| 4 | 2017 | 105 | |
| 5 | 2017 | 42 | |
| 6 | 2014 | 125 | |
| 7 | 2014 | 43 | |
| 8 | 2013 | 25 | |
| 9 | 2011 | 52 | |
| 10 | 2010 | 75 | |
| 11 | 2010 | 38 | |
| 12 | 2007 | 17 |
About Jane E. Willoughby
Jane E. Willoughby is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy, Oncology and Molecular Biology, having authored 12 papers that have together received 581 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), CAR-T cell therapy research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), IL-33, ST2, and ILC Pathways (1 paper) and Cell Adhesion Molecules Research (1 paper). The work is most often cited by research in Immunology (412 citations), Oncology (233 citations), Radiology, Nuclear Medicine and Imaging (122 citations), Immunology and Allergy (16 citations) and Cancer Research (34 citations). Jane E. Willoughby has collaborated with scholars based in United Kingdom, France and United States. Frequent co-authors include Aymen Al‐Shamkhani, Mark S. Cragg, Sarah L. Buchan, Jordana Griffiths, Ivo Tews, Vadim Y. Taraban, Peter Johnson, Tomasz Ślebioda, Anne Rogel and Tania F. Rowley. Their work appears in journals such as The Journal of Immunology, European Journal of Immunology, Scientific Reports, Mucosal Immunology and Molecular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.